Enhertu Approved in the US for the Treatment of Patients with Previously Treated HER2-Positive Advanced Gastric Cancer

First Patient Dosed in Phase II Trial of Debiopharm's Antiviral Alisporivir Against Covid-19

Metrion Biosciences and LifeArc extend neuroscience-Ion channel drug discovery collaboration for a further 12 months

GenSight Biologics provides update on cash position and operations

European Medicines Agency grants PRIME designation to Tessa Therapeutics' lead autologous CD30 CAR-T therapy

Grifols to start Spanish clinical trial for new COVID-19 drug

Genkyotex SA's Phase 1 study in oral setanaxib demonstrated tolerance at the doses of up to 1600mg/day for treating PBC

Feinstein Institutes to conduct USD4m research perinatal depression led by Dr Kristina Deligiannidis, MD

Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy

Janssen Receives FDA Approval of Darzalex Faspro as Treatment for Newly Diagnosed Patients with Light Chain Amyloidosis

Grifols Starts Clinical Trial of New Treatment to Provide Immediate Immunity Against COVID-19

Dr. Reddy's Laboratories to begin phase 3 study of Sputnik V vaccine in India

Sirnaomics completes dose administration for first patient in Phase 2a STP705 clinical study

Steba biotech receives US FDA Fast Track designation for padeliporfin IMmune Photo Activate Cancer Treatment

Jubilant Therapeutics collaborates with The Wistar Institute